A pH/temperature responsive nanocomposite for chemo-photothermal synergistic cancer therapy

dc.contributor.authorMustafa Rawand A.
dc.contributor.authorRan Meixin
dc.contributor.authorWang Yonghui
dc.contributor.authorYan Jiaqi
dc.contributor.authorZhang Yu
dc.contributor.authorRosenholm Jessica M.
dc.contributor.authorZhang Hongbo
dc.contributor.organizationfi=Turun biotiedekeskus|en=Turku Bioscience Centre|
dc.contributor.organization-code1.2.246.10.2458963.20.18586209670
dc.converis.publication-id178845894
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/178845894
dc.date.accessioned2025-08-28T03:31:21Z
dc.date.available2025-08-28T03:31:21Z
dc.description.abstract<p>To optimize synergistic breast cancer treatment, a nanocomposite was fabricated with pH-temperature responsive and chemo-photothermal combination therapy. Herein, <a href="https://www.sciencedirect.com/topics/medicine-and-dentistry/gold-nanorod" title="Learn more about gold nanorods from ScienceDirect's AI-generated Topic Pages">gold nanorods</a> (AuNRs) are coated with [poly[(N-isopropylacrylamide)-co-(methacrylic acid)] (p(NIPAM-co-MAA)) modified <a href="https://www.sciencedirect.com/topics/chemistry/mesoporous-silica" title="Learn more about mesoporous silica from ScienceDirect's AI-generated Topic Pages">mesoporous silica</a> (MS) for <a href="https://www.sciencedirect.com/topics/medicine-and-dentistry/doxorubicin" title="Learn more about Doxorubicin from ScienceDirect's AI-generated Topic Pages">Doxorubicin</a> (DOX) delivery (AuNR@DOX-MS@p(NIPAM-co-MAA)). Upon NIR radiation, the AuNR core induced hyperthermia via generating heat. Simultaneously, the polymer layer collapsed in response to high temperature/low pH, which allowed the triggering of DOX release from the MS shell at the tumor site. With this nanocomposite, nearly zero premature release of DOX at physiological pH/temperature was detected, while effective DOX release was reported at higher temperature/lower pH values. In addition, <em>in vitro</em> studies demonstrated that the nanocomposite has a substantial uptake efficiency of MDA-MB-231 breast <a href="https://www.sciencedirect.com/topics/medicine-and-dentistry/cancer-cell" title="Learn more about cancer cells from ScienceDirect's AI-generated Topic Pages">cancer cells</a>, with a significant increase in suppressing MDA-MB-231 ​cell proliferation in response to <a href="https://www.sciencedirect.com/topics/engineering/laser-irradiation" title="Learn more about laser irradiation from ScienceDirect's AI-generated Topic Pages">laser irradiation</a>. The <em>in vivo</em> experiments further verified the high efficiency of the fabricated nanocomposite in accumulating at the tumor site and the good capability in suppressing tumor growth in the mice upon <a href="https://www.sciencedirect.com/topics/medicine-and-dentistry/intravenous-drug-administration" title="Learn more about intravenous injection from ScienceDirect's AI-generated Topic Pages">intravenous injection</a>, while exhibiting good biosafety in relation to major organs in the body. Thus, the synthesized nanocomposite could be a potential <a href="https://www.sciencedirect.com/topics/medicine-and-dentistry/nanocarrier" title="Learn more about nanocarrier from ScienceDirect's AI-generated Topic Pages">nanocarrier</a> for breast cancer treatment with synergistic chemo-photothermal therapeutic capability.<br></p>
dc.format.pagerange199
dc.format.pagerange211
dc.identifier.eissn2590-1834
dc.identifier.jour-issn2590-1834
dc.identifier.olddbid210768
dc.identifier.oldhandle10024/193795
dc.identifier.urihttps://www.utupub.fi/handle/11111/55974
dc.identifier.urlhttps://doi.org/10.1016/j.smaim.2022.09.004
dc.identifier.urnURN:NBN:fi-fe2023031131270
dc.language.isoen
dc.okm.affiliatedauthorZhang, Hongbo
dc.okm.discipline3111 Biomedicineen_GB
dc.okm.discipline3122 Cancersen_GB
dc.okm.discipline318 Medical biotechnologyen_GB
dc.okm.discipline3111 Biolääketieteetfi_FI
dc.okm.discipline3122 Syöpätauditfi_FI
dc.okm.discipline318 Lääketieteen bioteknologiafi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherKeAi Communications Co.
dc.publisher.countryChinaen_GB
dc.publisher.countryKiinafi_FI
dc.publisher.country-codeCN
dc.relation.doi10.1016/j.smaim.2022.09.004
dc.relation.ispartofjournalSmart Materials in Medicine
dc.relation.volume4
dc.source.identifierhttps://www.utupub.fi/handle/10024/193795
dc.titleA pH/temperature responsive nanocomposite for chemo-photothermal synergistic cancer therapy
dc.year.issued2023

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
1-s2.0-S2590183422000461-main.pdf
Size:
3.15 MB
Format:
Adobe Portable Document Format